Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Meta Platforms (Facebook)
META
|
+$479M |
| 3 |
Evergy
EVRG
|
+$302M |
| 4 |
Johnson & Johnson
JNJ
|
+$298M |
| 5 |
Walmart
WMT
|
+$266M |
Top Sells
| 1 |
Home Depot
HD
|
+$623M |
| 2 |
Amazon
AMZN
|
+$555M |
| 3 |
Booking.com
BKNG
|
+$519M |
| 4 |
Eli Lilly
LLY
|
+$279M |
| 5 |
UnitedHealth
UNH
|
+$251M |
Sector Composition
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.44% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Globe Life
GL
$11.5B
| $6.61M | 0.01% |
81,200
-53,800
| -40% | -$4.38M |
|
|
VIAB
1602
DELISTED
Viacom Inc. Class B
VIAB
| $6.61M | 0.01% |
219,100
+32,900
| +18% | +$992K |
|
1603
Sanmina
SANM
$6.24B
| $6.6M | 0.01% |
+225,333
| New | +$6.6M |
|
1604
China Yuchai International
CYD
$1.46B
| $6.6M | 0.01% |
304,014
+115,814
| +62% | +$2.51M |
|
|
SMMF
1605
DELISTED
Summit Financial Group, Inc.
SMMF
| $6.57M | 0.01% |
244,935
-4,900
| -2% | -$132K |
|
1606
D.R. Horton
DHI
$53B
| $6.56M | 0.01% |
160,038
-924,800
| -85% | -$37.9M |
|
|
JNP
1607
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $6.54M | 0.01% |
752,173
+91,623
| +14% | +$797K |
|
1608
First Foundation Inc
FFWM
$493M
| $6.54M | 0.01% |
352,800
-4,500
| -1% | -$83.4K |
|
1609
Vaalco Energy
EGY
$419M
| $6.53M | 0.01% |
2,391,117
+318,046
| +15% | +$868K |
|
1610
Tronox
TROX
$767M
| $6.52M | 0.01% |
331,400
+312,400
| +1,644% | +$6.15M |
|
1611
First Hawaiian
FHB
$3.19B
| $6.5M | 0.01% |
224,000
+68,200
| +44% | +$1.98M |
|
|
BHR
1612
Braemar Hotels & Resorts
BHR
$203M
| $6.46M | 0.01% |
571,492
+461,974
| +422% | +$5.22M |
|
|
RVNC
1613
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.46M | 0.01% |
235,200
+85,300
| +57% | +$2.34M |
|
1614
ING
ING
$74.7B
| $6.44M | 0.01% |
449,810
-1,589,690
| -78% | -$22.8M |
|
|
AVDL
1615
Avadel Pharmaceuticals
AVDL
$1.5B
| $6.43M | 0.01% |
1,049,070
+267,270
| +34% | +$1.64M |
|
1616
Agilysys
AGYS
$2.97B
| $6.41M | 0.01% |
413,652
+92,152
| +29% | +$1.43M |
|
1617
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $6.41M | 0.01% |
133,490
+97,777
| +274% | +$4.69M |
|
1618
Red Rock Resorts
RRR
$3.65B
| $6.4M | 0.01% |
+191,100
| New | +$6.4M |
|
1619
Tootsie Roll Industries
TR
$2.92B
| $6.4M | 0.01% |
255,172
-35,500
| -12% | -$891K |
|
|
BRT
1620
BRT Apartments
BRT
$290M
| $6.4M | 0.01% |
501,860
+147,000
| +41% | +$1.87M |
|
1621
West Bancorporation
WTBA
$344M
| $6.4M | 0.01% |
254,300
+7,300
| +3% | +$184K |
|
1622
Standard BioTools
LAB
$493M
| $6.38M | 0.01% |
1,070,500
+118,200
| +12% | +$704K |
|
1623
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.4B
| $6.37M | 0.01% |
120,000
+27,200
| +29% | +$1.44M |
|
|
TTOO
1624
DELISTED
T2 Biosystems, Inc
TTOO
| $6.36M | 0.01% |
164
+130
| +382% | +$5.04M |
|
1625
Embraer
ERJ
$10.5B
| $6.33M | 0.01% |
254,300
-385,400
| -60% | -$9.6M |
|